These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 31773505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.
    Bundrant LA, Tzanis E, Garrity-Ryan L, Bai S, Chitra S, Manley A, Villano S.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180524
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Physiologically Based Pharmacokinetic Model for Predicting Omadacycline Pharmacokinetics and Pharmacodynamics in Healthy and Hepatic Impairment Populations.
    Zhang A, Sun Y, Zuo M, Wei H, Chen J, Zhao M, Yang W, Zhu L.
    Clin Ther; 2024 Aug; 46(8):629-635. PubMed ID: 39069431
    [Abstract] [Full Text] [Related]

  • 10. The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study.
    Hunt TL, Tzanis E, Bai S, Manley A, Chitra S, McGovern PC.
    Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):85-92. PubMed ID: 33180250
    [Abstract] [Full Text] [Related]

  • 11. Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections.
    Bhavnani SM, Hammel JP, Lakota EA, Liolios K, Trang M, Rubino CM, Steenbergen JN, Friedrich L, Tzanis E, Ambrose PG.
    Antimicrob Agents Chemother; 2024 Sep 04; 68(9):e0128123. PubMed ID: 39082883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model.
    Lepak AJ, Zhao M, Marchillo K, VanHecker J, Andes DR.
    Antimicrob Agents Chemother; 2017 May 04; 61(5):. PubMed ID: 28193651
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
    Bhavnani SM, Hammel JP, Lakota EA, Trang M, Bader JC, Bulik CC, VanScoy BD, Rubino CM, Huband MD, Friedrich L, Steenbergen JN, Ambrose PG.
    Antimicrob Agents Chemother; 2023 Apr 18; 67(4):e0221321. PubMed ID: 36946741
    [Abstract] [Full Text] [Related]

  • 15. Omadacycline: A New Tetracycline Antibiotic.
    Dougherty JA, Sucher AJ, Chahine EB, Shihadeh KC.
    Ann Pharmacother; 2019 May 18; 53(5):486-500. PubMed ID: 30917674
    [Abstract] [Full Text] [Related]

  • 16. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
    Tanaka SK, Steenbergen J, Villano S.
    Bioorg Med Chem; 2016 Dec 15; 24(24):6409-6419. PubMed ID: 27469981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.